{"generated_at":"2026-09-08T07:58:03.162Z","count":161,"rows":[{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"MAC","verdict":"partial","page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"Three of five models read this as partial; GPT 5.6 Sol voted bad because the clause affirmatively lets the vendor change MAC pricing under an ordinary course standard, and Gemini 3.1 Pro voted missing because none of the model's governance elements appear. Section 4.1(d) on page 4 addresses MAC pricing and limits changes to the ordinary course of business with a test protecting retail pharmacy participation, which is a real if soft guardrail. It does not require a single list for what the plan pays and what pharmacies are paid, does not require disclosure of the list, sets no update schedule and gives pharmacies no appeals path with timelines. The subject is addressed with narrower rights than the model, which is the definition of partial.","confidence":0.7,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"FID","verdict":"partial","page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"All five models reached this verdict. Section 2.3 has Express Scripts agree to act as a fiduciary in good faith with candor and due diligence, and section 5.4(b) on page 7 adds a warranty of utmost good faith, loyalty, candor and skill. That is an express fiduciary undertaking, which is rare in pharmacy benefit contracts, but the duty is framed around performance of the contract rather than loyalty owed solely to the plan and its members. There is no duty to disclose every form of direct and indirect compensation and no disgorgement remedy for value retained in breach, so the clause is weaker than the model contract published by Mark Cuban and collaborators.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"DISC","verdict":"partial","page_ref":"Page 22","evidence_quote":"PBM warrants and represents that, if at any time after the Effective Date of the Contract, PBM discovers or is made aware of an actual or perceived conflict of interest, appearance of impropriety or Prohibited Communication","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because there is no named officer certification. Article 16 on page 22 requires immediate written disclosure of actual or perceived conflicts of interest, and section 4.1(a) and 4.1(e) on page 4 confine the vendor's compensation to what the Fee Schedule lists and route manufacturer program fees to ERS. What is absent is a standing account of all direct and indirect compensation, any schedule of affiliate ownership touching plan claims, disclosure of payments to consultants or brokers, and a quarterly or annual certification by a named officer. Disclosure exists but is event driven rather than a certified accounting, which is the partial verdict.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"MFN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The consideration article on page 17 points to Exhibit B, the term article on pages 18 and 19 sets five years with a two year option and no repricing trigger, and page 13 allows performance standards to be adjusted once a year by mutual agreement, which is not a market check. Nothing promises the city pricing as good as comparable clients and there is no meet, credit or release remedy. The city's only lever during the term is termination on notice under page 29.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"FID","verdict":"bad","page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"All five models reached this verdict. Section 4.2 of the scope of services exhibit has the A&M System agree that Express Scripts is not a fiduciary of the plan under ERISA or state law, that it has no discretionary authority over the benefit, and that the financial terms were negotiated at arm's length. The only fiduciary role Express Scripts accepts is for handling an appeal, on page 114. The same page reserves the right to stop serving any plan in a state that requires a pharmacy benefit manager to be a fiduciary, which is the opposite of the duty of loyalty in the model contract published by Mark Cuban and collaborators.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"DISC","verdict":"bad","page_ref":"Page 115","evidence_quote":"Unlike the Administrative Fees, the revenues described in the Financial Disclosure are not direct or indirect compensation to ESI from A&M System for services rendered to A&M System or the Plan under this Contract.","rationale":"No verdict won a majority: GPT 5.6 Sol and Grok 4.6 read this as bad, Claude Opus 5 and Kimi K3 as partial, and Gemini 3.1 Pro as missing because there is no officer certification. The reconciliation rule takes the middle vote, which falls on bad, and a re-read of page 115 confirms the text is not merely silent. Section 4.3 points to a Financial Disclosure that lives in the unproduced proposal and that Express Scripts may update on its own, then declares those revenues are not compensation from the plan and that the plan has no interest in them. There is no plan specific accounting of retained revenue and no named officer who certifies quarterly or annually that everything has been disclosed and remitted.","confidence":0.5,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"OWN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and GPT 5.6 Sol called it partial because page 6 requires advance notice of any merger, acquisition or change of ownership. The exhibit list on page 17 runs from Exhibit A to Exhibit K and contains no ownership or affiliate disclosure exhibit. Accredo Health Group and Express Scripts Specialty Distribution Services are named as specialty pharmacies on page 110 and Medco Containment Life Insurance Company appears as the Medicare plan sponsor on page 116, but only inside operating definitions. Nothing lists owners, parents, group purchasing organizations or rebate aggregators, and nothing requires a refreshed list within 30 days of a change in control.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"DEF","verdict":"partial","page_ref":"Page 110","evidence_quote":"“Brand/Generic Algorithm” or “BGA” means ESI’s standard and proprietary brand/generic algorithm, a copy of which may be made available for review by Sponsor or its Auditor upon request.","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Kimi K3 voted unclear because seven numbered definitions on pages 110 to 112, apparently including rebate, manufacturer administrative fee and specialty product, are individually blacked out. The definitions that survive hand the labelling power to Express Scripts: brand versus generic status comes from its proprietary algorithm on page 110, the MAC list on page 111 is whatever it develops or selects, and the specialty product list on page 112 is maintained and updated by it. Those readable terms are addressed but weaker than the model contract, which defines each term by economic function. The redacted definitions keep confidence low because the terms that decide pass through cannot be tested.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"PASS","verdict":"bad","page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure and, accordingly, A&M System acknowledges that neither it, any Member, nor the Plan, has a right to receive, or possesses any beneficial interest in, any such fees or revenues; provided, that ESI will pay A&M System amounts equal to the amounts expressly set forth in this Contract.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Kimi K3 voted unclear because the rebate amounts and payment terms in Exhibit C-3 on pages 35 to 37 are blacked out. The readable structure is visible without those numbers. Page 114 says only that Express Scripts will pay the amounts set forth on Exhibit C, and section 4.3 on page 115 says Express Scripts and its affiliates keep the beneficial interest in every other manufacturer and affiliate revenue stream, with the plan owed only what the contract expressly states. That is a guaranteed amount arrangement in which the surplus stays with the vendor, not one hundred percent of manufacturer revenue of every kind. The redacted share keeps confidence moderate.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"NAC","verdict":"unclear","page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted bad because the page 24 heading prices ESI Mail Pharmacy on average aggregate annual ingredient cost and dispensing fee guarantees rather than at acquisition cost. Exhibit D, specialty drugs under the mail order pharmacy program, is fully blacked out from page 54 to page 106, and the ESI Mail Pharmacy guarantee section on page 25 survives only as headings. Pages 110 and 111 confirm that the mail and specialty pharmacies are owned by Express Scripts or its affiliates, so the pricing that would settle this item sits entirely under the redaction. The heading Grok 4.6 cited is a real signal, but a heading without its terms is not enough to score the item.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"CEIL","verdict":"unclear","page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted missing because the readable headings show aggregate guarantees and no ceiling clause appears anywhere in the visible text. A benchmark ceiling would live in the claims reimbursement rates and the general pricing terms of Exhibit C-2, and page 27 says the general pricing terms apply to all pricing in the contract before the text goes black. The surviving heading on page 24 describes average aggregate annual guarantees, which leans against a claim by claim test, but the operative terms cannot be read. Redaction, not silence, is the reason this cannot be decided.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"CASH","verdict":"unclear","page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted missing because the usual and customary price on page 112 is defined as a pharmacy reported cash amount and nothing readable caps what a member pays or credits a cash purchase to the deductible. The words accumulator and cash price do not appear in the readable text outside that definition. Whether members pay the lesser of the cash price and the plan price would be set in the general pricing terms of Exhibit C-2, which are blacked out on pages 27 to 33. Because the section that would carry the rule is redacted, the item stays unclear rather than missing.","confidence":0.75,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"MAC","verdict":"bad","page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules developed or selected by ESI.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Kimi K3 voted unclear because the pricing terms in Exhibit C-2 that might describe how the list is applied are blacked out. The readable definition on page 111 makes the maximum allowable cost list whatever Express Scripts develops or selects. Nothing in the readable text requires one list for what the plan pays and what pharmacies are paid, requires disclosure to the A&M System, sets an update schedule, or gives pharmacies an appeal path with deadlines. A vendor controlled list with none of those safeguards is the mechanism the model clause exists to block.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.991+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"SPRD","verdict":"unclear","page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Four of five models read this as unclear; Claude Opus 5 voted partial because page 4 defines a bona fide dispute as Express Scripts billing the A&M System an amount other than the amount reimbursed to the pharmacy. That definition and the audit protocol on page 127 suggest a pass through arrangement for retail claims exists, but the protocol frames it as something the sponsor might or might not have, and the claims reimbursement rates and general pricing terms on pages 24 to 34 are blacked out, as is every mail and specialty rate in Exhibit D. Whether the plan pays exactly what the pharmacy is paid in every channel cannot be read, so the item is redaction blocked.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"GPO","verdict":"bad","page_ref":"Page 115","evidence_quote":"act on their own behalf, and not for the benefit of or as agents for A&M System, Members or the Plan.","rationale":"Three of five models read this as bad; Grok 4.6 voted missing because the words group purchasing organization never appear, and Kimi K3 voted unclear because the rebate exhibit on pages 35 to 37 is blacked out. No clause allocates purchase discounts, volume credits or supplier payments collected by an affiliated purchasing entity to the plan. Section 4.3 on page 115 goes further than silence: Express Scripts and its affiliates negotiate those revenues on their own behalf, not as agents for the plan, and keep them. That is the outcome the model contract's purchasing entity pass through exists to prevent.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"FORM","verdict":"partial","page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"All five models reached this verdict. The formulary is developed by the Express Scripts pharmacy and therapeutics committee and selected or adopted by the sponsor, then changed by Express Scripts over time for reasons that expressly include manufacturer rebate arrangements. Additions and deletions are adopted by the sponsor automatically unless the A&M System elects not to implement them through a set up form on page 111. Page 113 does give the sponsor final say on whether any claim is covered. That is an opt out veto, not the advance approval of every change, lowest net cost analysis and quarterly utilization reporting the model contract requires.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; Kimi K3 voted bad because the formulary definition on page 110 names manufacturer rebate arrangements as a reason to move drugs on and off the list. The formulary definition on page 110 and the formulary support clause on page 114 say nothing about net cost to this plan, and no clause promises an annual comparison against the vendor's book of business or requires disclosure when a drug is placed above a cheaper equivalent. The phrase net cost does not appear in the readable text. The rebate factor Kimi K3 flagged is real and is already counted in the formulary verdict, but the lowest net cost standard itself is simply absent.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"NET","verdict":"bad","page_ref":"Page 112","evidence_quote":"Subject to Applicable Law, ESI will make Members aware of the ability to fill their prescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings, and provide supporting services (e.g. pharmacist consultation) in connection with any prescription dispensed by the ESI Mail Pharmacy.","rationale":"Three of five models read this as bad; Kimi K3 called it partial because page 4 returns pharmacy audit recoveries to the plan, and Gemini 3.1 Pro called it missing because no protective network clause exists. Page 112 authorizes Express Scripts to promote its own mail pharmacy to members and lets it consolidate networks and migrate the plan between networks on its own. Participating pharmacies are defined on page 111 to exclude affiliated mail and specialty pharmacies. Nothing readable gives any willing pharmacy a right to join, bars retroactive clawbacks or bars reimbursement tied to volume, and page 4 lets Express Scripts keep 15% of what it recovers from network pharmacies. Affiliate steering written into the services exhibit is the harm the model clause prevents.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"MFN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Gemini 3.1 Pro and Kimi K3 voted unclear because a market check could in principle sit in the blacked out pricing exhibit. The readable text runs the other way: page 2 freezes the Exhibit C pricing terms for the term unless both parties agree in writing or the law requires a change, and page 115 reopens pricing only after a change in law. The words most favored and market check appear nowhere in the readable text, and the Exhibit C headings on pages 21 to 52 show no market check section. The clause is absent from the text that can be read, so the majority verdict of missing stands.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"AUD","verdict":"partial","page_ref":"Page 127","evidence_quote":"The Sponsor may select an initial number of manufacturer contracts to enable Sponsor to audit fifty percent (50%) of the total Rebate payments due to Sponsor for two (2) calendar quarters during the twenty-four (24) month period immediately preceding the audit","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it bad because the auditor must be approved by Express Scripts and may not be a competitor or provide litigation services against it. The audit right is real: page 3 gives one claims audit a year at no cost over a rolling 24 months and acknowledges the Texas State Auditor, and pages 126 and 127 allow rebate and performance guarantee audits. It is also fenced on every side. A rebate audit covers only half of the rebate payments for two quarters, manufacturer contracts may be viewed on site with no copies, Express Scripts may review the auditor's notes, and follow up is capped at 300 claims. Routine delivery of claims level data without asking is not promised. The right exists but is materially weaker than the model contract.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"DATA","verdict":"partial","page_ref":"Page 4","evidence_quote":"All such records, including any research, reports, studies, data, or other documents that are specifically generated by ESI for the A&M System and are specific to its program under this Contract, shall be the property of the A&M System","rationale":"Three of five models read this as partial; GPT 5.6 Sol called it bad because page 8 makes anonymized claims data and mail and specialty pharmacy data the property of Express Scripts, and Gemini 3.1 Pro called it missing because no clause names the sponsor sole owner. Page 4 makes program specific records, reports and data the property of the A&M System with delivery on written request at termination, and page 8 assigns member identifiable health information and eligibility files to the System. The same page 8 clause hands anonymized claims data, mail and specialty pharmacy data, rebate contracts and drug pricing information to Express Scripts, and the business associate agreement on page 130 lets it create and use de identified data. Ownership is addressed but split, with no machine readable delivery duty and no ban on reuse of anonymized plan data.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"PERF","verdict":"unclear","page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"All five models reached this verdict. Performance guarantees exist, because the audit protocol on page 126 lists performance guarantees subsequent to true up as an auditable component and page 3 refers to performance standards obligations. The guarantees themselves, how often they are measured, whether they use plan specific data and whether shortfalls are paid in cash or as capped credits sit in Exhibit C, which is blacked out apart from headings on pages 21 to 53. The surviving headings on page 24 describe average aggregate annual guarantees, but no remedy language can be read.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"ENF","verdict":"partial","page_ref":"Page 127","evidence_quote":"To the extent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding adjustments to Sponsor through credits to a future invoice(s).","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Grok 4.6 called it missing because there are no liquidated damages and no two strikes exit. Remedies here depend on agreement rather than running on their own. Page 127 returns money only after both parties accept the audit results, through credits to a future invoice, and a new audit cannot start until the last one is closed. Page 5 allows termination for material breach after a 45 day cure period, page 6 allows immediate termination on a change of control and page 9 allows termination if Express Scripts knowingly fails its Public Information Act duties. Those are real remedies, which is why the item is weaker than the model rather than absent, but none of them is automatic and none is triggered by a second breach.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"AMD","verdict":"good","page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"Four of five models read this as good; Claude Opus 5 called it partial because page 117 of the Medicare addendum lets the Express Scripts affiliate equitably modify the program pricing terms on its own if the number of Part D eligible retirees falls materially. Page 5 requires every amendment to be in writing and signed by both parties, and page 2 says Express Scripts will not revise the Exhibit C pricing terms during the term unless required by law or by written agreement. A change in law on page 115 reopens fees and rebates, but if the parties cannot agree either side may terminate rather than Express Scripts rewriting terms by notice. The Medicare carve out Claude Opus 5 found is genuine and keeps confidence below the unanimous level, but the core rule meets the model.","confidence":0.75,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"TERM","verdict":"good","page_ref":"Page 5","evidence_quote":"the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"Four of five models read this as good; Gemini 3.1 Pro called it partial because the text does not expressly protect earned amounts from forfeiture or name a regulatory integrity event. Page 5 lets the A&M System terminate without cause on ninety days written notice with no fee, penalty or wind down charge stated, and either party may terminate for uncured material breach after 45 days. Page 6 allows immediate termination if Express Scripts is acquired, page 12 covers loss of legislative funding, and page 9 allows termination for a knowing failure of Public Information Act duties. The Medicare addendum on page 125 lets the affiliate delay final rebate and subsidy payments for reconciliation, which is a hold, not a forfeiture.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"SPEC","verdict":"unclear","page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"All five models reached this verdict. Exhibit D, specialty drugs under the mail order pharmacy program, is blacked out from page 54 through page 106, the specialty product pricing section on page 25 has no surviving text, and the specialty rebate amounts on page 35 are blacked out. The readable text shows on page 110 that the specialty pharmacies are Accredo Health Group and Express Scripts Specialty Distribution Services, both affiliates, and on page 112 that the specialty product list is maintained and updated by Express Scripts. Whether specialty is defined by function, whether drug level rates act as ceilings and whether affiliate specialty claims are priced at acquisition cost cannot be seen.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","rubric_key":"GAG","verdict":"bad","page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it to be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"All five models reached this verdict. Exhibit F on page 109 designates the contract, Exhibit C program pricing terms, Exhibit D specialty and mail order terms and Exhibit E clarifications as confidential and proprietary and claims they are exempt from the Texas Public Information Act, and page 9 lets Express Scripts designate still more. The confidentiality clause on page 8 treats rebate contracts, manufacturer administrative fee information and drug pricing information as Express Scripts property. The A&M System must still comply with the Act and must notify Express Scripts of requests so it can argue for an exemption, but that is only a right to contest release. The result is visible in this posting: the prices the plan pays are blacked out.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:50.992+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"OWN","verdict":"partial","page_ref":"Page 10","evidence_quote":"PBM agrees to notify ERS¶ Executive Director immediately upon being able to lawfully make a public announcement of reaching any form of binding agreement in connection with and prior to any merger, acquisition, business reorganization, or other material change of PBM¶s management, ownership or business structure","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because the exhibit list on page 34 contains no ownership or affiliate disclosure exhibit and the insurance pages are not a disclosure document. Section 8.1 on page 10 requires immediate notice of any merger, acquisition or change of ownership or control, section 4.1(i) on page 4 names Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. as the affiliated specialty pharmacies, and the insurance declaration pages at pages 55 to 58 happen to list many related entities including MATRIX GPO, LLC. None of that is a signed exhibit that maps every owner, affiliate, purchasing entity and rebate aggregator with a duty to refresh it within 30 days. The re-read confirms the disclosure is real but incidental, so the majority verdict stands with low confidence because the two missing votes make a fair point.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"DEF","verdict":"partial","page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"All five models reached this verdict. The rebate definition at section 4.1(i) on pages 5 and 6 is broader than most contracts of its era, sweeping in price protection dollars, price concessions, discounts and any other remuneration, and section 4.1(e) on page 4 folds manufacturer program fees into the same bucket. The definition is then limited on page 6 to amounts received under a contract with a pharmaceutical manufacturer and related to utilization of formulary drugs, so revenue routed through a purchasing entity or tied to non formulary drugs sits outside it. Specialty is defined by which affiliate dispenses rather than by economic function, and generic and pharmacy are not defined at all in the base text.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"PASS","verdict":"partial","page_ref":"Page 5","evidence_quote":"PBM shall pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed to HealthSelect Medicare Rx PDP or HealthSelect PDP Participants. Such Rebates shall be paid to ERS by PBM promptly, but in no event later than on a quarterly basis until all such compensation has been received by ERS.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro voted good because the clause says all rebates and the definition is broad. Section 4.1(h) on page 5 commits Express Scripts to pay all defined Rebates and all federal subsidies to ERS at least quarterly, which is a genuine pass through promise. It falls short of the model in three ways: the promise is qualified by the words as set forth herein and in Exhibit D, and page 5 says rebates are paid at the applicable rate described in the Fee Schedule, so the text does not itself establish one hundred percent; the definition on page 6 reaches only manufacturer contract payments tied to formulary utilization; and there is no 30 day settlement deadline or closed list of excludable claims. Exhibit D is a cover sheet on page 39, so the operative rate cannot be read.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"NAC","verdict":"unclear","page_ref":"Page 39","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted missing because no clause in the base text requires acquisition cost pricing. Pages 3 and 4 define PBM Mail Pharmacy and PBM Specialty Pharmacy as channels owned by Express Scripts or its affiliates, so affiliate dispensing is built into the design, and section 4.1(a) on page 4 places every compensation and reimbursement schedule in the Fee Schedule attached as Exhibit D. Exhibit D is present only as the cover sheet on page 39; the document says the schedule exists but its text is not posted. Because the pricing method for affiliate claims lives in a document that is referenced but withheld from the posted text, the item is unclear rather than missing.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"CEIL","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; Gemini 3.1 Pro voted unclear on the theory that a ceiling might sit in Exhibit D. The substantive votes overrule that, because the base agreement never points to the Fee Schedule for any ceiling and does not use the concept at all. Article 4 on page 4 fixes Medi-span as the AWP pricing source and constrains MAC changes, but nothing caps a claim at a published benchmark or a transparent cash price in any channel, and nothing tests cost claim by claim. The amendments, supplement and service addendum are silent as well.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"CASH","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. No provision protects a member from paying more through the plan than the pharmacy cash price, and the words cash price, usual and customary, accumulator and out of pocket maximum do not appear in the contractual text. Section 9.8 on page 12 compensates a participant for vendor error and the service addendum spreads Medicare Part D cost sharing over monthly invoices, but neither counts a cash purchase toward the deductible or bars accumulator adjustments. The subject is absent from every document read.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"SPRD","verdict":"unclear","page_ref":"Page 39","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted missing because no sentence in the base text bars or permits a spread. The word spread never appears. Section 4.1(a) on page 4 commits the reimbursement schedule and administrative fees to the Fee Schedule attached as Exhibit D, and section 4.1(f) on page 5 shows the claims flow, with Express Scripts paying pharmacies first and then being reimbursed by ERS as provided in the RFP. Whether the reimbursement equals what the pharmacy was paid plus a disclosed fee, or is a guaranteed discount arrangement that lets the vendor keep a difference, is decided entirely inside Exhibit D and the RFP, which are present only as cover sheets on pages 36 and 39. The pricing method is referenced but withheld, so the item is unclear.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"GPO","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The contract never mentions group purchasing organizations, rebate aggregators or purchasing coalitions, and no clause routes purchase discounts, volume credits or supplier payments received by such entities to the plan. The rebate definition on pages 5 and 6 reaches only remuneration received by the PBM under a contract with a pharmaceutical manufacturer, so revenue collected by a related purchasing entity sits outside the pass through duty by construction. The insurance pages at pages 55 to 58 list MATRIX GPO, LLC among the named insureds, which shows such an affiliate exists, yet nothing requires its revenue to flow to ERS.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"FORM","verdict":"partial","page_ref":"Page 5","evidence_quote":"the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"All five models reached this verdict. ERS holds a real approval right: section 4.1(c) on page 4 requires written ERS approval of any material change to plan design including the formulary, and section 4.1(h) on page 5 requires prior approval by ERS representatives for formulary changes. The same sentence names manufacturer rebate arrangements as an accepted reason to change the formulary, which is the incentive the model contract exists to neutralize, and the formulary remains the PBM's own list. There is no lowest net cost analysis with each change and no quarterly report of utilization management outcomes by drug.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. No provision imposes a lowest net cost standard on formulary decisions for this plan, requires an annual comparison against the vendor's whole book of business, or requires disclosure when a drug is placed above a cheaper equivalent. Section 4.1(h) on page 5 allows a formulary management program with cost containment initiatives subject to ERS review, which is a process right rather than a cost standard, and section 31.6 on page 29 compares aggregate contract pricing across customers rather than formulary economics. Nothing in the amendments, supplement or service addendum fills the gap.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"NET","verdict":"partial","page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because none of the model's four protections appears. The re-read supports both camps. Section 5.4(d) on page 7 gives ERS sole discretion to implement an alternate retail network with a duty of cooperation, and section 4.1(d) on page 4 bars MAC changes that would discourage retail pharmacy participation, so the plan has some network leverage. But there is no statement that claims are final when adjudicated, no bar on retroactive clawbacks, no bar on volume conditioned reimbursement, no anti steering rule even though affiliated mail and specialty pharmacies are named on pages 3 and 4, and no any willing pharmacy right. The majority verdict stands because the subject is touched, with low confidence because the protections that matter most are absent.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"MFN","verdict":"partial","page_ref":"Page 29","evidence_quote":"PBM warrants and represents that if, during the term of this Contract, PBM enters into any agreement with any other governmental customer or any commercial customer not affiliated with PBM, of a similar size or smaller (the Comparative Agreement), by which PBM agrees to perform, deliver or provide equivalent Services, coverages, benefits, supplies or products that PBM is providing in accordance with this Contract for more generous pricing terms","rationale":"All five models reached this verdict. Section 31.6 on page 29 is a genuine most favored pricing clause: if Express Scripts gives a similar or smaller government or unaffiliated commercial customer more generous aggregate pricing, the contract shall be amended at ERS' sole option to give equivalent advantage, and the vendor must notify ERS and document the determination. Its limits are that the comparison is measured in the aggregate rather than line by line, only customers of similar size or smaller count, and Express Scripts itself decides whether a comparative agreement is more generous. There is no annual independent market check with a meet, credit or release remedy.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"AUD","verdict":"partial","page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"Three of five models read this as partial; Claude Opus 5 and Kimi K3 voted good because the audit right is unusually broad. Section 15.5 on page 18 gives ERS an absolute audit right that expressly reaches the vendor's contracts with pharmaceutical manufacturers, section 15.6 adds Texas Insurance Code 1551.067 access to facilities, records and subcontractor agreements and shifts audit costs to the vendor when errors exceed $50,000, section 5.7 on page 9 gives ERS on premises access to claims data, and section 15.13 on page 19 says nothing in the proposal narrows these rights. Three limits keep it short of the model: third party auditors must sign a non disclosure agreement with the vendor, rebate agreement audits under section 15.12 on page 19 are limited to the portions an approved auditor deems necessary and scheduled by agreement, and section 14.3 on page 16 lets the vendor withhold third party pricing data as Third-Party IP. There is no pre adjudication claims access. A strong audit clause with real carve outs is partial.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"DATA","verdict":"partial","page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program (the ³GBP´) as applicable","rationale":"Three of five models read this as partial; Kimi K3 voted good because ownership, non reuse and portability are all present, and GPT 5.6 Sol voted bad because the business associate agreement lets the vendor keep de-identified data forever. Section 13.6 on page 14 makes confidential information, which section 13.4 on page 13 says includes all claims and membership records, the exclusive property of ERS, and section 21.2 on page 26 requires delivery of all ERS related records and data at no cost in a format that needs no specialized software. Against that, section 14.2 on page 16 reserves systems, methodologies and standard reporting to the vendor, section 3.1(2) of the business associate agreement on page 45 permits Express Scripts to de-identify protected health information and maintain it indefinitely, and the service addendum lets participant contact data go to a third party supplier. Ownership of the records is clear while reuse of derived data is not barred, which is weaker than the model.","confidence":0.7,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"PERF","verdict":"unclear","page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"All five models reached this verdict. Section 5.5 on page 7 incorporates performance guarantees as Exhibit E, which appears in the base document only as the cover sheet on page 40. Amendment 2 replaces that exhibit with First Amended and Restated Performance Guarantees, and Amendment 2 page 4, where those guarantees appear, is fully redacted. Whether the guarantees are measured quarterly on plan specific data, reconciled in cash, or paid dollar for dollar rather than as capped credits cannot be read.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"ENF","verdict":"partial","page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract, whichever ERS determines is appropriate.","rationale":"All five models reached this verdict. Article 9 gives ERS liquidated damages of up to $10,000.00 per default or per calendar day without proving actual damages, section 4.1(g) on page 5 lets ERS offset sums owed against the vendor's fees, and Article 11 on page 12 makes all remedies cumulative. Termination for cause is immediate in ERS' sole opinion under section 2.4(a) on page 2. The remedy is discretionary rather than self executing, the figure is a ceiling rather than a schedule, a notice and cure period generally applies, and there is no defined two strikes exit after a repeat breach or regulatory integrity failure. The performance guarantee credits themselves sit in the redacted Amendment 2 page 4.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"AMD","verdict":"good","page_ref":"Page 2","evidence_quote":"The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"Three of five models read this as good; GPT 5.6 Sol voted bad and Grok 4.6 voted partial because the service addendum says Express Scripts shall give 30 days written notice before changing the pricing structure of the Medicare Prescription Payment Plan program. Section 2.6 on page 2 permits change only by a written agreement executed by both parties, section 4.1(b) on page 4 holds the Fee Schedule unchanged for the term absent mutual written agreement, and the two amendments and the supplement in this record were in fact signed by both sides. The service addendum sentence on page 2 of that document sits directly beneath a sentence saying program changes after the first year require mutual written agreement, so it reads as a notice duty layered on consent rather than a unilateral repricing right, but the two dissenters are right that the drafting is loose and covers a fee whose amount is redacted. The majority verdict stands with reduced confidence.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"TERM","verdict":"good","page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"Four of five models read this as good; Gemini 3.1 Pro voted partial because the text does not expressly say earned amounts are never forfeited. Section 2.4 on page 2 lets ERS terminate for cause immediately, without cause on ninety days notice, by mutual agreement, or if the Board does not approve funds, and no termination fee appears anywhere in the documents. Section 4.3 on page 6 requires a pro rata refund of prepaid fees within two business days, section 4.1(h) on page 5 continues rebate payments until ERS has received all such compensation, and Article 21 on page 26 requires transition cooperation and delivery of records at no cost. Nothing conditions earned rebates on the contract continuing, so the model's protections are present.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"SPEC","verdict":"unclear","page_ref":"Page 39","evidence_quote":null,"rationale":"Four of five models read this as unclear; Grok 4.6 voted partial because the base text names the affiliated specialty pharmacies without defining specialty by function or setting a ceiling. Section 4.1(i) on page 4 defines PBM Specialty Pharmacy as Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc. and other affiliate pharmacies that primarily dispense Specialty Products, and Specialty Products is never defined. Every drug level rate, channel ceiling and any acquisition cost term for affiliate specialty claims sits in the Fee Schedule that section 4.1(a) incorporates as Exhibit D, present only as the cover sheet on page 39. The specialty pricing controls are referenced but their text is withheld, so the item is unclear.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","rubric_key":"GAG","verdict":"partial","page_ref":"Page 15","evidence_quote":"ERS and, subject to a non-disclosure agreement with PBM, its auditors, advisors, consultants, and custodians, if applicable, are entitled to use and retain copies of all written materials generated by PBM under this Contract.","rationale":"Three of five models read this as partial; Claude Opus 5 and Kimi K3 voted good because the confidentiality article runs against the vendor and nothing bars ERS from releasing pricing, rebate or performance data. The re-read shows why the majority saw a limit. Section 13.1 on page 13 confirms ERS is subject to the Texas Public Information Act, and section 13.11 on page 15 tells the vendor to assume its reports may be public records and says ERS has no duty to advocate for the vendor's confidentiality claims, which is favorable. In the same section, ERS' auditors, advisors and consultants may use vendor materials only subject to a non disclosure agreement with the vendor, the vendor may label materials confidential or proprietary and gets notice and a right to argue to the Attorney General against release, and the service addendum is stamped Confidential Information with its fee redacted on page 5. Nothing restricts pharmacies from telling members about cheaper options, and Supplement 1 has the vendor supporting the federal gag clause attestation. A public records posture with vendor labelling rights and an NDA condition on advisors is partial, which sets the red flag.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.423+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"FID","verdict":"bad","page_ref":"Page 26","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this Agreement to United “administering the Plan” are descriptive only and do not confer upon United any responsibilities or duties beyond the claim administration duties set forth herein.","rationale":"Three of five models read this as bad; GPT 5.6 Sol and Gemini 3.1 Pro called it partial because page 10 warrants that services will be performed with the care of a prudent claims administrator or fiduciary and page 34 names United a fiduciary for initial claim determinations and first level appeals. We re-read pages 10, 26 and 34. The fiduciary role is confined to claim decisions, page 26 disclaims any duty beyond claim administration, and nothing requires loyalty to the plan when United sets MAC lists, tiers drugs, or keeps spread, purchase discounts and float interest. There is no conflict disclosure duty and no disgorgement remedy, so the contract permits the self dealing the model clause by Mark Cuban and collaborators exists to prevent. The prudent administrator warranty is a real but narrow counterweight, which is why confidence is moderate.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"DISC","verdict":"partial","page_ref":"Page 67","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to Lockton (“Consultant”). The Consultant Fees are included in Customer’s pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmpm.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because no clause requires a complete accounting of compensation. The text does disclose several revenue streams: the $2.00 per member per month consultant fee paid to Lockton through the pharmacy terms on page 67, access fees and marketing charges collected from network pharmacies on page 42, an affiliate transaction fee of 1% to 3% on provider payments on page 60, and the 80 percent medical rebate share on page 58. None of these come with totals, there is no disclosure of affiliate ownership touching plan claims, and no named officer certifies quarterly or annually that everything has been disclosed and remitted. The subject is addressed piecemeal, which is weaker than the model rather than absent.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"OWN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The exhibit list on page 2 and the attachments to Exhibit D contain no schedule of owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, or mail and specialty pharmacies, and there is no duty to refresh ownership information after a change in control. The only affiliate references are the definitions on pages 41 and 42 that fold United affiliates into the home delivery and specialty pharmacy definitions, and the Form CIQ on pages 85 and 86 concerns conflicts with City officers rather than PBM ownership.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"DEF","verdict":"bad","page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"All five models reached this verdict. The Rebate definition on page 41 is written by label and carve out rather than by economic function: money received for direct purchases, payments to a group purchasing organization, and payments for products, services, tools or data analytics are all written out of the definition, and Price Protection is defined separately. Page 66 then confirms that Manufacturer Administrative Fees sit outside the guaranteed rebate arrangement. Brand and generic status follow Medi-Span codes and MAC pricing is whatever United places on lists it controls. These definitions let manufacturer value be relabeled so it never reaches the pass through, which is the loophole the model contract by Mark Cuban and collaborators closes.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"PASS","verdict":"partial","page_ref":"Page 64","evidence_quote":"Minimum Rebate Guarantee (Traditional PDL) Rebate Sharing Percentage 100.0% 100.0% 100.0%","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Gemini 3.1 Pro called it bad because page 45 states that United retains affiliate purchase discounts and purchase rebates and does not pass them on. We re-read pages 41, 45, 64, 65 and 66. The City is promised a 100.0% share of defined Rebates with per script minimums, so the subject is addressed and money does flow, but the promise is narrowed from every side. Rebate excludes direct purchase money, group purchasing organization receipts and service payments on page 41, Manufacturer Administrative Fees are excluded on page 66, page 45 lets United pursue other manufacturer revenue and keep affiliate purchase discounts, and pages 64 and 65 exclude a long list of claim types. The first payment can arrive 210 days after the quarter and later payments within 90 days, not 30. Under the majority rule this is a weaker version of pass through rather than a contradiction, but the minority reading is strong enough that confidence is low.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"NAC","verdict":"bad","page_ref":"Page 45","evidence_quote":"United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"All five models reached this verdict. Pages 41 and 42 make United affiliates network pharmacies in the home delivery and specialty channels, page 45 says those affiliates keep the purchase discounts and purchase rebates on drugs they buy, and pages 43 and 67 let United keep the difference between what the pharmacy is paid and what the City pays. Nothing invoices affiliate claims at acquisition cost plus a stated dispensing fee and there is no documentation default. Affiliate pharmacies are priced by average wholesale price discount with margin retained, the opposite of the model rule.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"CEIL","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The pharmacy pricing on pages 63 through 69 is built entirely on average wholesale price discounts measured in the aggregate over a year, with no cap tied to a published benchmark or transparent cash price and no claim by claim test. The usual and customary charge defined on page 42 and the lesser of three rule on page 67 limit what a member pays at the counter, not what the plan pays, and no other section addresses a ceiling.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"CASH","verdict":"partial","page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"All five models reached this verdict. Page 67 gives members half of what the model asks for: at a network pharmacy they pay the lesser of the discounted price, the pharmacy reported cash price or their cost share, so a member should not pay more through the plan than the counter price the pharmacy reports. The text says nothing about crediting a cash purchase made outside the benefit toward the deductible or out of pocket maximum, and nothing about accumulator adjustments against manufacturer assistance, so the protection is present but narrower than the model.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"MAC","verdict":"bad","page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"All five models reached this verdict. Page 41 allows multiple maximum allowable cost lists changed at United sole discretion, with no requirement that the same list govern what the City pays and what pharmacies are paid, no disclosure to the City, no update schedule and no pharmacy appeal path anywhere in the document. Combined with the retained spread language on pages 43 and 67, this is the two list structure the model clause exists to prevent.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"SPRD","verdict":"bad","page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"All five models reached this verdict. Spread pricing is stated in plain words three times: page 43 for home delivery, retail and specialty, page 67 for mail order, specialty and retail drugs and services including dispensing fees, and page 69 again for specialty drugs. The model contract requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee. Here the City has no contractual way to learn what the pharmacy actually received, and page 43 also lets United keep the interest earned on claim funds between withdrawal and pharmacy payment.","confidence":1,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"GPO","verdict":"bad","page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"All five models reached this verdict. The Rebate definition on page 41 writes anything a group purchasing organization receives out of the pass through, page 45 lets United pursue other revenue from drug manufacturers directly or indirectly, and the same page states that affiliate purchase discounts and purchase rebates are retained and not passed on. No clause allocates purchasing entity money to the City on any driver. The contract preserves exactly the purchasing entity revenue channel the model clause is written to capture.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"FORM","verdict":"partial","page_ref":"Page 44","evidence_quote":"While Customer is the ultimate decision-maker on selecting the design of Customer’s PDL(s), Customer has requested that United supply and assist Customer with certain PDL development and management functions including but not limited to drug tiering decisions.","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Gemini 3.1 Pro called it bad because page 44 gives United the final classification of every drug to a tier, weighing economic factors that expressly include available Rebates. We re-read pages 43 and 44. The City is named the ultimate decision maker on the design of its drug list and chooses among United lists, which is a real if limited sponsor role. The working levers stay with the vendor: United makes the final tier call, provides negative change notices only on request, withholds its utilization management criteria from the City and its vendors, and must approve any customization. No lowest net cost analysis or quarterly utilization management outcomes are promised. Under the majority rule this is sponsor control weaker than the model rather than its absence, and the minority reading is recorded here.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; GPT 5.6 Sol and Kimi K3 called it bad because page 44 lets United weigh available Rebates when it places a drug on a tier and page 65 lets United cut the rebate guarantee if the City deviates from the list. We re-read pages 44, 45 and 65. No clause states a lowest net cost standard for this plan, no annual comparison against United book of business is promised, and nothing requires disclosure when a drug is placed above a cheaper equivalent. The only mention of lower net drug cost is on page 65, where United reserves the right to change the arrangement if list changes made to lower net cost for its customers reduce rebates. Because the rebate factor on page 44 is one input to tiering rather than an affirmative permission to favor high rebate drugs, the majority treated the standard as absent rather than contradicted, and the minority view is recorded here.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"NET","verdict":"bad","page_ref":"Page 42","evidence_quote":"Customer engages United or its affiliate as its exclusive provider of the prescription drug benefit services set forth in this Agreement.","rationale":"Three of five models read this as bad; GPT 5.6 Sol called it partial because page 42 promises reasonable notice of material network changes, and Gemini 3.1 Pro called it missing because no clause speaks to clawbacks or any willing pharmacy terms. We re-read pages 41, 42 and 67. Page 42 makes United or its affiliate the exclusive provider of pharmacy benefit services, pages 41 and 42 place the United owned home delivery and specialty pharmacies inside the network, page 67 conditions every pricing guarantee on that exclusivity across retail, mail and specialty, and the same page lets United revise or revoke the pricing if the City hires a vendor that helps members find cheaper drugs or pharmacies. United may add or remove pharmacies at will and no clause makes adjudicated claims final or lets any willing pharmacy join. The text does more than stay silent; it builds in affiliate steering and penalizes the City for steering elsewhere.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"MFN","verdict":"partial","page_ref":"Page 66","evidence_quote":"Customer may conduct one market check during the Pharmacy Pricing Term to confirm its financial terms are competitive with those currently available in the market for substantially similar customers.","rationale":"All five models reached this verdict. Page 66 gives the City one market check during the three year pricing term, initiated in the third quarter after the first anniversary, run by a mutually agreed third party against at least four similar customers, and comparing aggregate value rather than claim level pricing. If the report shows more than three percent annualized savings against the median the parties only negotiate in good faith, with any change effective the following contract year and only if an amendment is signed 60 days ahead. There is no most favored customer promise and no meet, credit or release remedy, so the item is present but weaker than the model.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"AUD","verdict":"partial","page_ref":"Page 46","evidence_quote":"Once each calendar year during the term of the Agreement or any applicable runout period, a mutually agreeable entity, on behalf of Customer, may conduct a pharmacy claims audit for purposes of determining if United is administering its claims transactional services in accordance with Plan provisions.","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Gemini 3.1 Pro called it bad because page 46 caps rebate review at the lesser of the top five agreements or agreements covering 75% of rebate revenue and forbids the auditor from copying or retaining any rebate document. We re-read pages 10, 42 and 46. A genuine audit right exists, with access to all of the City claims, and page 10 gives the City general access to books and records. But the auditor must be mutually agreeable and sign a United confidentiality agreement, United must agree to the place, time, type, scope and duration, the look back is 18 months, December and January are off limits, each period may be audited only once, the City pays, and routine reporting is limited to United standard online reports on page 42 with no pre adjudication access. Under the majority rule this is a constrained right rather than a denial, though the rebate copying ban brings it close to the line.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"DATA","verdict":"bad","page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate’s own behalf.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Kimi K3 called it partial because page 14 bars either party from selling, licensing or commercially reusing the other party confidential information. We re-read pages 14, 47 and 50. No clause makes the City the owner of its claims, eligibility, accumulator or rebate data, and there is no right to machine readable delivery on request. Page 50 lets United de-identify the City health data and use and disclose it on its own behalf, page 14 lets United answer post termination information requests at its discretion and for a fee, and page 47 limits transition help to twelve file transmissions in United standard format. The de-identified reuse right is exactly what the model clause forbids, so the majority verdict stands, with the page 14 restriction on selling confidential information noted as a partial counterweight.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"PERF","verdict":"partial","page_ref":"Page 61","evidence_quote":"With respect to the aspects of United’s performance addressed in this exhibit, these Fee adjustments are Customer’s exclusive financial remedies.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it bad because the service guarantees are capped at flat amounts such as $11,000 per metric on page 61. Attachment D-6 does contain real guarantees: pharmacy discount, dispensing fee and rebate guarantees on pages 64 and 68 are customer specific and the shortfall is paid in dollars. But measurement and payment are annual rather than quarterly, the service guarantees are small capped credits often measured at the office or site level rather than on this plan, page 61 makes fee credits the City exclusive financial remedy, force majeure and legal change carve outs excuse United, and pages 65 to 68 give United many rights to revise or revoke the pharmacy guarantees. Guarantees exist but the remedies are weaker than the model.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"ENF","verdict":"partial","page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Grok 4.6 called it missing because there are no liquidated damages and no two strikes exit anywhere in the document. We re-read pages 11, 46 and 61. Page 61 does convert missed guarantees into automatic fee credits without the City proving damages, which is the self executing half of the model design, and page 64 pays pharmacy shortfalls in dollars. The other half is absent: no liquidated damages for late reports, audit recoveries on page 46 require a mutually signed settlement, page 11 requires a 30 day cure before any termination for cause, and nothing gives the City a penalty free exit after a second material breach or a regulatory integrity event. Under the majority rule the automatic credit makes this weaker than the model rather than unaddressed.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.853+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"AMD","verdict":"bad","page_ref":"Page 5","evidence_quote":"Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive.","rationale":"Three of five models read this as bad; Grok 4.6 and Kimi K3 called it partial because page 16 says the contract can be modified only by a writing signed by both parties. We re-read pages 5, 16, 61 and 65 to 67. The bilateral rule on page 16 is real, but Exhibit A on page 5 lets the contractor change fees on 30 days notice at each renewal by delivering a replacement Attachment D-5, and change them at any time when the plan, the law or enrollment shifts by 10% or more, with the new fee effective retroactively; the City only recourse is to terminate. Page 61 lets United specify new guarantees and replace the exhibit, and pages 65 to 67 let United revise or revoke the pharmacy pricing on many triggers. Economic terms can move by notice, which is the harm the model clause exists to prevent, so the majority verdict stands.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.854+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"TERM","verdict":"bad","page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination of pharmacy benefit services and no reconciliation of minimum rebate guarantees will apply.","rationale":"Four of five models read this as bad; Grok 4.6 called it partial because page 11 lets either party terminate without cause after the initial term. We re-read pages 11, 55, 59 and 66. Convenience termination is available only after the three year initial term, on notice the text renders as thirty (120) calendar days. Leaving the pharmacy benefit early forfeits every pending and future rebate and cancels the minimum guarantee reconciliation on page 66, page 59 repeats the forfeiture for any exit other than for cause, page 45 lets United raise medical fees if pharmacy services end, and page 55 requires repayment of the administrative and wellness credits on early termination. Earned amounts are forfeited and no regulatory integrity event is a termination ground, which is the trap the model clause exists to prevent.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.854+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"SPEC","verdict":"bad","page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"Four of five models read this as bad; Grok 4.6 called it partial because the specialty definition on pages 41 and 42 is functional, requiring at least three of eight clinical and handling criteria. The definition is the only element that meets the model. United designates the specialty drug list on page 46, may move a drug off specialty based on market conditions on page 68, prices specialty as an annual aggregate average wholesale price discount of 21.00% for listed drugs and 14.00% for unlisted drugs rather than as drug level ceilings, includes its own specialty pharmacy in the network, and on page 69 keeps the spread on every specialty claim. Specialty claims at the affiliate pharmacy are not priced at acquisition cost, which is the core of the model rule.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.854+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","rubric_key":"GAG","verdict":"bad","page_ref":"Page 13","evidence_quote":"Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"Four of five models read this as bad; Kimi K3 called it partial because page 14 carves out disclosures required by law including public records acts and page 13 says the public nature of material is judged under the Texas Public Information Act. We re-read pages 13, 14 and 58. Pricing, discounts, reimbursement terms, payment methodologies and compensation arrangements are defined as Confidential Information, the City may use them only for plan administration, United may require a confidentiality agreement before any disclosure, and on a public records request the City must give immediate notice and cooperate in seeking a protective order. That is a duty to help block release, not a clean carve out, so the guidance that a carve out letting the vendor seek to block release does not make a bad into a good applies. Page 58 promises language to support the City anti gag attestation, and nothing restricts pharmacies from telling members about cheaper options, but the fee pages themselves are stamped proprietary. The red flag is set.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:51.854+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"FID","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The agenda request on pages 1 to 3, the pharmacy memorandum on pages 8 to 11 and the consultant notes on pages 16 to 18 describe a transparent business model and a fee only compensation promise, but no passage makes Envision owe a duty of loyalty or care to the county or its members, and there is no disgorgement remedy. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"DISC","verdict":"partial","page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Grok 4.6 called it missing because a single fee promise is not a disclosure covenant. The consultant records on page 17 that Envision will put in writing that it accepts only its per employee per month fee and no other money tied to the county's drug spend, and page 11 prints that fee as $3.50. That is a real statement about compensation, but there is no schedule of direct and indirect compensation, no affiliate or consultant payment disclosure and no officer certification on any cycle. Page 10 also warns that additional fees for services are in the contract that is not attached, so the packet addresses the subject without meeting the model.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"OWN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. No page contains a signed list of owners, parents, subsidiaries, group purchasing organizations, rebate aggregators or owned pharmacies, and nothing requires Envision to refresh such a list. The only corporate relationships named are the Costco partnership for mail and specialty on page 10 and the note on pages 4 and 8 that the outgoing vendor OptumRx is a United Healthcare subsidiary. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"DEF","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Rebate, pharmacy discounts, mail order, specialty and administrative fee are all used in the pricing summary on pages 10 and 11 and in the narrative on pages 2 and 17, but none is defined anywhere. Without a definitions article there is no way to tell whether the 100 percent pass through promise reaches administrative fees, data fees or other manufacturer payments. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"PASS","verdict":"partial","page_ref":"Page 10","evidence_quote":"agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"Four of five models read this as partial; Kimi K3 called it good because the page 11 table adds rebate minimums of $17.35 per Brand Rx at retail and $66.60 per Brand Rx at mail to the 100 percent pass through label. The county's memorandum on page 10 says Envision has agreed in contracts to pass through 100 percent of all monies received or earned through county utilization, and page 17 adds that rebates arrive at the point of sale rather than after a year end reconciliation. The promise is broad on its face, but the packet gives no definition of the money covered, no payment schedule, no closed list of excluded claims and no audit right, and the operative contract is not in the file. A summary of a proposal term cannot be read as the enforceable clause the model contract published by Mark Cuban and collaborators requires, so the majority verdict stands.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"NAC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because the no spread sentence on page 10 reaches mail and specialty. Page 10 describes a Costco partnership for mail and specialty pharmacy, and page 11 prices mail order as discounts off average wholesale price with no dispensing fee. Nothing invoices claims at any related pharmacy at net acquisition cost plus a stated fee, and there is no documentation default. A no spread promise is a different protection from acquisition cost pricing, so the subject is not addressed.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"CEIL","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The pricing summary on pages 10 and 11 sets discounts off average wholesale price but never caps what the plan pays against a published benchmark or a cash price, and there is no claim by claim test. The subject does not appear in the memoranda or the consultant notes on page 17. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"FID","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and Kimi K3 called it bad because Section 3.8 on page 4 makes IPM an independent contractor and not an agent of the county. We re-read pages 2 to 4 and the relationship clause in Section 16 on page 9. Nothing imposes a duty of loyalty or care on IPM, requires disclosure of conflicts, or provides for disgorgement, and the independent contractor language describes the legal relationship rather than authorizing self dealing. Under the majority rule the item is not addressed rather than contradicted, and the minority reading is recorded here.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"DISC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The only compensation terms are the fees in Exhibit A on page 11 and the billing article on pages 4 and 5. Nothing requires IPM to disclose affiliate ownership, related entity revenue or payments to consultants or brokers, and no officer certifies anything on any schedule. Section 3.7 on pages 3 and 4 puts a disclosure duty on the county toward its members, not on IPM toward the county.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"OWN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because page 12 requires a Texas Form 1295 certificate of interested parties at award, renewal or amendment. We re-read page 12. The Form 1295 clause is a state procurement requirement aimed at the bidder's interested parties, not a signed exhibit listing owners, subsidiaries, affiliated pharmacies, purchasing organizations or rebate aggregators, and it carries no duty to refresh within 30 days of a change in control. Exhibit A is a fee sheet and Exhibit B is a HIPAA business associate agreement, so no ownership exhibit exists.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"DEF","verdict":"bad","page_ref":"Page 1","evidence_quote":"\"Average Wholesale Price\" or \"A WP\" will mean the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"Four of five models read this as bad; Grok 4.6 called it partial because a definitions article does exist. The definitions on pages 1 and 2 let IPM pick the pricing benchmark in its sole discretion, decide what counts as a brand name drug, and determine generic status using a combination of data fields it never discloses. Rebate, manufacturer revenue, affiliate, specialty and MAC are not defined at all. Because the terms that drive price are set by the vendor rather than by economic function, the definitions do the opposite of what the model contract by Mark Cuban and collaborators requires.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"PASS","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The word rebate appears twice, in Section 3.7 on page 4 where the county must disclose rebates to members and in Section 24 on page 10 where taxes on rebate amounts are the county's cost. Neither clause promises the county any share of manufacturer revenue, sets a remittance schedule or lists excludable claims. On this text the county has no contractual claim to any rebate at all.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"NAC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The recitals on page 1 mention a network of retail and mail order pharmacies, but Exhibit A on page 11 prices only retail claims at discounts off average wholesale price plus dispensing fees. Nothing prices claims from IPM owned or related pharmacies at acquisition cost, and there is no documentation default if acquisition records are not produced.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"CEIL","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; Claude Opus 5 called it partial because the generic line in Exhibit A on page 11 lists usual and customary charge as one pricing alternative. We re-read page 11. The generic formula names average wholesale price less a discount, usual and customary or generic MAC without saying which applies or that the lowest controls, brand claims have no ceiling at all, and no clause tests any claim against a published cash benchmark in any channel. That is not a benchmark ceiling, so the majority reading stands.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"CASH","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Section 5.7 on page 5 stops IPM and network pharmacies from billing members beyond copayments and deductibles, which is a real protection but a different one. Nothing says a member never pays more than the pharmacy cash price, nothing credits cash purchases toward a deductible, and nothing addresses accumulator adjustments.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"MAC","verdict":"partial","page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"Three of five models read this as partial; Claude Opus 5 called it bad because the MAC list is never tied to what pharmacies are paid, and Gemini 3.1 Pro called it missing because no governance clause exists. The phrase Generic MAC appears only in the Exhibit A fee line on page 11, so a MAC list does affect what the county pays. The agreement never defines the list, never discloses it, never puts it on an update schedule, never says one list governs both county billing and pharmacy payment, and gives pharmacies no appeals path. The subject is touched by the pricing exhibit but none of the governance the model contract requires is present, which is the partial verdict.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"ENF","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 called it bad because Section 9.6 on page 7 caps IPM's liability at six months of administrative fees, and GPT 5.6 Sol called it partial because Section 4 on page 4 allows termination for an uncured material breach. We re-read pages 4 and 7. There are no liquidated damages, no automatic credits, no report deadlines and no two strikes exit, so nothing self executing exists. The liability cap and the 30 day cure right are real weaknesses, and they are recorded in the termination and audit findings, but they do not address the subject of automatic remedies. Under the majority rule the item is not addressed.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"SPRD","verdict":"bad","page_ref":"Page 5","evidence_quote":"Client understands that IPM ' s agreements w ith Network Pharmacies may allow etwork Pharmacies to review payments made by IPM related to the Covered Pharmacy Services.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Kimi K3 called it missing because no clause speaks to spread in words. We re-read pages 4, 5 and 11. The county is billed at the average wholesale price formulas in Exhibit A, while Section 5.8 confirms that pharmacy payment terms live in IPM's separate agreements with network pharmacies, and Section 5.2 says the money the county sends is not an asset of the plan. Nothing requires the county to pay what the pharmacy is paid plus a disclosed fee, so the structure permits IPM to keep the difference in every channel. The majority reading stands, with reduced confidence because the permission comes from structure rather than an express retention clause.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"GPO","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. No group purchasing organization, volume credit, purchase discount or supplier payment appears in the definitions on pages 1 and 2, the compensation article on pages 4 and 5, Exhibit A on page 11 or anywhere else in the 17 pages.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"FORM","verdict":"partial","page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because the word formulary never appears. We re-read pages 3 and 4. Section 3.8 gives the county sole authority to control and administer its plans, and Sections 3.1 and 3.2 make the county supply the benefit design and approve changes to it, which is a real if general form of control. There is no formulary approval right, no lowest net cost analysis and no utilization management reporting by drug, and Section 2.1 on page 2 lets IPM change the Services on its own. The majority reading of partial stands because the county controls plan design even though it does not control the drug list.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The benefit design clauses on pages 3 and 4, the reporting clause in Section 2.7 on page 3 and Exhibit A on page 11 contain no lowest net cost standard, no annual comparison against IPM's book of business and no duty to explain when a drug is placed above a cheaper equivalent.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"NET","verdict":"bad","page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"Four of five models read this as bad; Gemini 3.1 Pro called it missing because no protective clause exists to be weaker than the model. Section 2.3 on page 2 puts network composition entirely in IPM's discretion with no promise about which or how many pharmacies participate, so there is no any willing pharmacy right and no anti steering rule. Section 5.8 on page 5 then makes the county remit money whenever a pharmacy later claims an underpayment, which is the opposite of claims being final when adjudicated. The text permits the harms the model clause exists to prevent.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"MFN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Pricing lives in Exhibit A on page 11 and in Section 5.3 on page 4, which lets IPM change fees after the first year. Nothing promises the county pricing as good as any comparable client and nothing creates a market check with a meet, credit or release remedy.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"AUD","verdict":"partial","page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because the only audit clause sits in the HIPAA exhibit. We re-read pages 3, 5 and 16. The audit right in Exhibit B, section 7 on page 16 lets either party audit compliance with the business associate agreement and inspect records of protected health information, not claims pricing or vendor revenue. The main agreement gives the county only IPM's standard reports as amended from time to time under Section 2.7 on page 3, deems reports accurate if not disputed within 45 days under Section 3.6, and requires payment in full while an invoice is disputed under Section 5.5 on page 5. An audit right exists but it does not reach the money, which is partial.","confidence":0.75,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"DATA","verdict":"bad","page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"All five models reached this verdict. Section 7.1 on page 6 lets IPM use, reproduce or adapt member information in any manner it deems appropriate, including product research and development, and Section 6.5 on the same page makes IPM's databases, adjudication logic and report formats IPM's copyrighted property. Section 7.2 lets IPM use de identified information as it sees fit. The county is never named owner of its claims, eligibility or rebate data, nothing requires machine readable delivery on request, and nothing bars reuse or resale. This is the reverse of the model contract's data ownership clause.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"PERF","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. No performance guarantee, quarterly measurement on plan specific data, cash reconciliation or dollar for dollar shortfall payment appears in the services article on pages 2 and 3, Exhibit A on page 11 or the liability and termination sections on pages 4 and 7.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"AMD","verdict":"bad","page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"Three of five models read this as bad; Grok 4.6 and Kimi K3 called it partial because Section 18 on page 9 requires mutual signed consent for amendments. We re-read pages 4 and 9. Section 18 opens with the words except as otherwise set forth herein, and Section 5.3 on page 4 is exactly such an exception: after the first year IPM may change the fees or other pricing on its own, with only documentation delivered before the county budget cycle. Section 2.1 on page 2 also lets IPM change the Services from time to time, and Exhibit B on page 17 adopts HIPAA driven changes without a signed amendment. The economic terms can move without the county's signature, which is the harm the model clause exists to prevent.","confidence":0.75,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"TERM","verdict":"partial","page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"All five models reached this verdict. Section 4 on page 4 lets the county end the agreement on 90 days notice with no stated termination fee, and the fiscal funding clause in Section 27 on page 12 adds a budget based exit each fiscal year. The catch is that a notice termination takes effect only at the end of the then current one year term, and the agreement renews automatically, so a late decision means another year, while the exclusivity clause on page 8 blocks the county from lining up another vendor meanwhile. There is no regulatory integrity trigger. Useful but weaker than the model's clean exit.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"SPEC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Exhibit A on page 11 lists only retail pharmacy fees and the recitals on page 1 mention mail order pharmacies. Specialty is never defined, no drug level specialty rate exists, and nothing prices affiliate specialty claims at acquisition cost anywhere in the 17 pages.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","rubric_key":"GAG","verdict":"bad","page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"All five models reached this verdict. Section 6.1 on page 5 defines confidential information to include pricing information and the agreement itself with all exhibits, which sweeps in the Exhibit A fee schedule. Section 6.2 bars either party from revealing that information without the other's written consent, which may be withheld for any reason, and the only stated exception in Section 6.3 is a subpoena with notice so the other party can object. There is no carve out for the Texas Public Information Act, the county's auditors or advisors, elected officials or the public, and Section 6.6 on page 6 backs the clause with injunctive relief. This is the red flag the item tracks.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.12+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"CASH","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Nothing protects a member from paying more through the plan than the pharmacy cash price, and nothing addresses whether a cash purchase counts toward the deductible or out of pocket maximum. The closest passage is the point of sale rebate design on page 17, which lowers what a member pays at the counter but is not a cash price ceiling and says nothing about accumulators. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"MAC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Maximum allowable cost appears on pages 10 and 11 only as the label for the current OptumRx generic pricing, while the proposed Envision generic rates are stated as discounts off average wholesale price. There is no statement that one list governs both what the county pays and what pharmacies are paid, no update schedule and no pharmacy appeal path. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"SPRD","verdict":"good","page_ref":"Page 10","evidence_quote":"has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"Three of five models read this as good; Claude Opus 5 and Grok 4.6 called it partial because the sentence is a county summary of a proposal rather than executed adjudication language, and because the same pages present guaranteed discounts off average wholesale price that could still differ from what a pharmacy is paid. The pharmacy memorandum on page 10 states that Envision agreed to a complete pass through of all pharmacy discounts with no spread pricing on retail, mail or specialty pharmacy, page 11 shows the PBM's compensation as a separate $3.50 per employee per month administrative fee, and page 17 records that Envision will accept only that fee. That is the structure the model contract published by Mark Cuban and collaborators asks for, so the majority verdict stands. Confidence is held down because the enforceable clause, the definition of the pharmacy payment and any reconciliation duty are in the executed agreement, which is not in the file.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"GPO","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because the phrase all monies received or earned on page 10 is broad enough to reach purchasing entity revenue. No page names a group purchasing organization, rebate aggregator, volume credit or supplier payment, and there is no allocation method. Page 10 says Envision contracts directly with pharmacies rather than using rental networks, which speaks to network fees, not purchasing entity revenue. A general phrase without a clause is not a GPO pass through, so the subject is not addressed.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"FORM","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because page 10 describes formulary management responsive to county needs. That sentence praises Envision's flexibility through formulary management, which is a vendor capability, not a grant of approval rights to the county. Nothing says the county approves the formulary or its changes, receives lowest net cost analysis or gets utilization management outcomes by drug. Page 9 lists a covered drug list as a bid evaluation criterion only. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. There is no lowest net cost standard for formulary decisions and no annual comparison against Envision's whole book of business anywhere in the 18 pages. The claim repricing described on pages 10 and 17 was a one time procurement exercise, not an ongoing contractual standard, and nothing requires disclosure when a drug is placed above a cheaper equivalent. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"NET","verdict":"partial","page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because the executed network terms are absent. Page 10 says members may fill 90 day prescriptions at retail instead of being required to use mail order, and pages 10 and 11 price a 90 day retail network, which is a real protection against steering members into one channel. Page 10 also describes more than 67,000 retail pharmacies contracted directly rather than rented. None of the other model protections appear, including finality of adjudicated claims, a bar on retroactive clawbacks, a ban on volume conditioned reimbursement and an any willing pharmacy right, and nothing forbids steering to the Costco mail and specialty partner.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"MFN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Pricing is fixed in the summary tables on pages 10 and 11 with no most favored client promise and no annual market check, and there is no meet, credit or release remedy. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"AUD","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; Kimi K3 called it partial because page 9 lists claim level repricing and standard, custom and ad hoc reporting among the bid evaluation criteria. Those lines describe how proposals were scored, not a continuing right for the county to audit with its own auditor, receive claims level financial data on a schedule or see claims before adjudication. Page 10 describes integrating pharmacy and medical data for case management, which is a service, not an audit right. No audit article appears in the packet, so the subject is not addressed.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"DATA","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The only data language is on page 10, where Envision and United Healthcare commit to integrating pharmacy data with medical data for case and disease management, which describes a use of data rather than who owns it. Nothing makes the county the owner of claims, eligibility, accumulator or rebate data, requires machine readable delivery or bars reuse or sale. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"PERF","verdict":"partial","page_ref":"Page 10","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan. In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"All five models reached this verdict. Pages 2 and 10 record substantial performance guarantee monies for service and a proposed 9.5 percent spend reduction guarantee over current pharmacy costs, and page 11 adds rebate minimums of $17.35 per Brand Rx at retail and $66.60 per Brand Rx at mail. Guarantees plainly exist, but the packet does not say how they are measured, whether they use Travis County data, whether shortfalls are paid in cash or as capped credits, or how often they are reconciled. The guarantee exhibit that would answer those questions is not part of the backup.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"ENF","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Nothing makes a missed guarantee or a late report trigger liquidated damages or an automatic credit, there is no two strikes exit and no regulatory integrity trigger. Pages 2 and 10 say guarantee money was proposed but do not say how it is enforced. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"AMD","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. Page 3 labels the contract type as annual and unilateral and page 16 says the three year term runs unless changed by Travis County, but neither line is an amendment procedure. Nothing requires amendments to be signed by both parties or bars changes to economic terms by notice or updated exhibit. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.","confidence":0.97,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"TERM","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because the page 16 phrase unless changed by Travis County suggests county control over the term. Page 3 gives a contract period of October 1, 2014 through September 30, 2015 and page 16 gives a three year term ending on a September 31, 2017 date that does not exist, so the packet does not even agree with itself on the term. Neither passage grants termination for convenience, sets notice, waives penalties or protects earned rebates and guarantee amounts on exit. A statement of term is not a termination clause, so the subject is not addressed.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"SPEC","verdict":"partial","page_ref":"Page 10","evidence_quote":"Envision’s proposal includes a partnership with Costco for mail and specialty pharmacy and has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because there is no specialty definition, rate table or ceiling. Page 10 extends the no spread promise to specialty pharmacy and names a Costco partnership for mail and specialty, which is the only specialty control a reader can see. The rate tables on pages 10 and 11 cover retail, 90 day retail and mail order and contain no specialty discounts, dispensing fees or drug level ceilings, and nothing prices specialty claims at acquisition cost. The subject is touched but far short of the model, and the executed specialty terms are not in the file.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","rubric_key":"GAG","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and Kimi K3 called it good because nothing in the 18 pages treats pricing, rebates or fees as confidential and the discount rates, dispensing fees, rebate minimums and administrative fee are printed in a public agenda record. The packet contains no confidentiality article and no pharmacy communication clause, because it is not the executed agreement, so whether the contract restricts the county from sharing pricing data or restricts pharmacies from telling members about cheaper options cannot be read from this file. Nothing is redacted, so the verdict is missing rather than unclear. A missing verdict does not raise the gag flag, and readers should not take that as proof the signed contract has no confidentiality clause.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.342+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"FID","verdict":"bad","page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"All five models reached this verdict. Section 2.5(B) on page 11 has the vendor accept a fiduciary role only for initial claim adjudication and appeals, and then states that for everything else it is not the plan administrator, not a named fiduciary, has no discretionary authority and is not deemed a fiduciary under ERISA or state law. Formulary placement, MAC pricing and manufacturer money therefore sit outside any duty of loyalty to the city. The model contract published by Mark Cuban and collaborators requires loyalty and care owed solely to the plan across the whole relationship, and page 10 confirms the vendor keeps manufacturer fees, so this is the opposite of the model.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"DISC","verdict":"partial","page_ref":"Page 10","evidence_quote":"may receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies, including, without limitation, administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost","rationale":"Three of five models read this as partial; Gemini 3.1 Pro called it missing because no clause requires a full compensation inventory or an officer certification, and Kimi K3 called it bad because the disclosure mainly authorizes retention. The disclosure of manufacturer fees on pages 9 and 10 does tell the city that the vendor and its affiliates take manufacturer administrative fees of one to four percent of wholesale acquisition cost across the book of business, plus purchase discounts at affiliated pharmacies, and section 21.3 on page 28 warrants that no contingent fee was paid to win the contract. Nothing requires the amounts actually earned on city claims to be reported, no affiliate ownership touching claims is listed, and no named officer certifies quarterly or annually. The subject is addressed, so the majority verdict of partial stands, but it is far weaker than the model.","confidence":0.7,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"OWN","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and GPT 5.6 Sol called it partial because section 14.3 on page 21 requires sixty days notice of a change in ownership interest greater than fifty percent or a change of control. That notice clause is real, but it is not an exhibit listing owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators or mail and specialty pharmacies, and nothing requires a refreshed list within thirty days of a change. The exhibit list on page 32 names performance guarantees, fees, the business associate agreement, SBEDA, the request for proposal and the proposal, not an ownership schedule, and the conflict of interest article on pages 27 and 28 concerns city officers and employees. The contract refers to affiliates and vendor owned pharmacies repeatedly without naming any of them, so the majority verdict stands.","confidence":0.7,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"DEF","verdict":"bad","page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"All five models reached this verdict. Section 1.12 on page 2 defines Rebates by label as formulary rebates, base and market share, collected as a group purchasing organization on brand drugs. Page 10 then removes fees, other compensation and concurrent or retrospective purchase discounts from the term and assigns them exclusively to the vendor or its affiliates. Brand and generic status are whatever the vendor identifies from Medi-Span on pages 1 and 2, the MAC list is a price the vendor establishes and amends, and specialty on page 3 is what the vendor uses. These are the relabeling loopholes that the definitions section of the model contract published by Mark Cuban and collaborators is written to close.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"PASS","verdict":"bad","page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"All five models reached this verdict. Page 9 promises to remit the Rebates received on city claims each quarter under Exhibit B, and Exhibit B is not in the posted document, so neither the share nor the timing can be read. What can be read is decisive on its own: page 10 lets the vendor and its affiliates receive and retain manufacturer administrative fees of one to four percent of wholesale acquisition cost and affiliate purchase discounts, and declares that this money belongs exclusively to the vendor and is not a Rebate. Page 9 also waives any interest or time value on rebate money and lets the vendor delay remittance on termination. That contradicts the one hundred percent pass through of all manufacturer revenue in the model contract, whatever Exhibit B says about the defined Rebates.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"NAC","verdict":"bad","page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro called it missing because no clause sets acquisition cost pricing, and Kimi K3 called it unclear because the rates would sit in the withheld Exhibit B. The pages are readable and the body text addresses the subject, so the unclear vote is overruled under rule 3 and the majority stands. Page 4 runs claims at the vendor's own mail and specialty pharmacies through the same lowest of discounted rate, usual and customary and MAC formula as retail, and page 10 states that purchase discounts on products bought by vendor affiliated dispensing pharmacies belong exclusively to the vendor or its affiliates. That is a retained affiliate margin in plain words, the harm the acquisition cost clause in the model contract published by Mark Cuban and collaborators exists to remove. Page 18 adds that the city funds payments to the vendor's affiliated pharmacies.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"CEIL","verdict":"partial","page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be the lowest of the discounted rate, the Participating Pharmacy’s reported U&C price, if applicable, and the VENDOR MAC rate, if applicable), plus the applicable dispensing fee","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because a lesser of clause is not a published external benchmark. Page 4 does give a claim by claim test: the ingredient cost is the lowest of the discounted rate, the pharmacy's reported usual and customary price and the vendor MAC rate. That stops the plan paying more than the pharmacy's own shelf price at a network pharmacy, which is a ceiling of a kind and is checked on every claim rather than on average. It is not the model standard because the benchmark is the pharmacy's self reported price rather than a transparent published cash price, and mail and specialty claims run on rates in the withheld Exhibit B with no stated ceiling. The majority verdict stands.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"CASH","verdict":"partial","page_ref":"Page 4","evidence_quote":"shall collect from the Plan Member the lowest of the applicable co-payment, the discounted price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Three of five models read this as partial; Gemini 3.1 Pro and Kimi K3 called it missing because most of what the item asks for is absent. Pages 4 and 5 require network pharmacies to collect from the member the lowest of the copayment, the discounted price, the vendor MAC rate or the pharmacy's usual and customary price, so a member should not pay more at the counter than the pharmacy's own cash price. That is the first half of the model clause. There is no promise that a cash purchase made outside the benefit counts toward the deductible or out of pocket maximum, and accumulator adjustments are not mentioned anywhere in the text. The subject is addressed in part, so the majority verdict of partial stands with reduced confidence.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"MAC","verdict":"bad","page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR in maintaining its generic pricing program.","rationale":"Four of five models read this as bad; Claude Opus 5 called it partial because the city receives a copy of the list before signing and on reasonable request. Section 1.9 on page 2 makes MAC a unit price the vendor establishes and amends from time to time, on a list that is specific to the city and expressly not the federal list. There is no update schedule, no pharmacy appeal path with deadlines, and nothing says the list used to bill the city is the same list used to pay pharmacies. A vendor controlled, client specific MAC list is the mechanism the model contract published by Mark Cuban and collaborators names as the classic spread tool, so the majority verdict stands.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"SPRD","verdict":"bad","page_ref":"Page 15","evidence_quote":"CITY acknowledges that, except as expressly set forth herein, it shall not be entitled to audit agreements with vendors, pharmaceutical companies, Participating Pharmacies or other providers of products or services to VENDOR as part of a Claims audit.","rationale":"Two of five models read this as bad, two as missing, and Kimi K3 voted unclear because the discount rates sit in the withheld Exhibit B. The pages that decide the question are readable, so the unclear vote is overruled under rule 3, leaving a tie between bad and missing that the rule sends back to the text. On re-read, the contract is not merely silent: page 4 defines what the city pays as a vendor set discounted rate, the pharmacy's usual and customary price or the vendor MAC rate, page 2 makes that MAC a list applicable to the city that the vendor maintains for its generic pricing program, page 5 says pharmacies are paid under their own network agreements with the vendor, and page 15 bars the city from auditing those agreements. The city's price and the pharmacy's payment are set on separate tracks and the contract blocks the one check that would reveal a difference, which permits retained spread in every channel. Confidence is low because no sentence says the vendor keeps the difference.","confidence":0.5,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"GPO","verdict":"bad","page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"All five models reached this verdict. Page 9 has the city authorize the vendor to contract with drug makers as a group purchasing organization for the plan, and page 10 then assigns the fees, compensation and concurrent or retrospective purchase discounts collected in that role exclusively to the vendor or its affiliates. The non interference clause on page 10 also bars the city from seeking rebates or discounts from any manufacturer or third party on its own for the whole term and calls a breach material. The model contract published by Mark Cuban and collaborators sends purchasing entity revenue to the plan on disclosed drivers; here it is kept.","confidence":0.98,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"FORM","verdict":"bad","page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"All five models reached this verdict. The city adopted the vendor's own Performance Drug List as its formulary, and section 1.10 on page 2 says that list is created, maintained and amended by the vendor and approved by the vendor's own committee. Page 8 gives the city thirty days notice before a drug is added, removed or moved between tiers, and page 9 gives quarterly notice of changes to the specialty formulary, but notice is not approval and the city has no right to reject a change or to receive a lowest net cost analysis. The party that collects the rebates decides which drugs are preferred, which is what the formulary section of the model contract published by Mark Cuban and collaborators exists to prevent.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Four of five models read this as missing; GPT 5.6 Sol called it partial because page 8 lists cost effectiveness among the reasons the vendor may change the drug list. That list on page 8 is a menu of things the vendor may consider, among other things, and it binds the vendor to nothing for this plan. There is no lowest net cost standard, no annual comparison of the city's results against the vendor's book of business, and no duty to disclose when a drug sits above a cheaper equivalent. The performance standards on pages 13 and 14 measure service accuracy and the audit article on pages 14 to 17 covers claims and rebates, so the majority verdict stands.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"NET","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and Gemini 3.1 Pro called it bad because page 5 gives the vendor the sole right to audit participating pharmacies and to recover audit discrepancies from them. That clause is real and it does mean pharmacies face recoupment after adjudication, but it governs billing errors under the vendor's network agreements rather than authorizing steering or volume based pay. Pages 4 to 7 describe independent participating pharmacies and the vendor's own mail and specialty pharmacies without any anti steering promise, any willing pharmacy clause, any bar on volume conditioned reimbursement or any statement that claims are final when adjudicated. The subject the model clause covers is not addressed, so the majority verdict stands.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"AUD","verdict":"partial","page_ref":"Page 15","evidence_quote":"CITY, or a mutually acceptable independent third party retained by CITY, may conduct an annual Claims audit and such audit shall be limited to the prior Contract Year of VENDOR data that directly relates to Claims billings.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it bad because the limits are heavy. The city does have real rights: an annual claims audit and an annual rebate audit on pages 14 and 15, a post termination audit on page 30, annual SOC 1 reports and audited financial statements on page 17, and claims data through an online portal on page 7. Every right is then narrowed: one on site audit per plan year, an auditor who must be mutually acceptable and sign the vendor's confidentiality form, no access to pharmacy or manufacturer agreements, a cap of ten manufacturer contracts in the rebate audit whose terms may not be revealed even to the city, vendor comment on the draft report, and a sample of three hundred claims in the standard timeline on page 16. That is weaker than the model, which gives the plan its own auditor and full data on a schedule, but the rights exist, so the majority verdict stands.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"DATA","verdict":"partial","page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Gemini 3.1 Pro called it bad because the vendor may sell deidentified plan data. Section 8.1 on page 19 gives the city ownership of information produced solely and exclusively for it, and section 22.5 on page 29 says all files are city property and must be delivered at termination, which is a genuine ownership clause. The same section 8.1 then reserves the vendor's trade secret rights inside that information and lets the vendor use, adapt and sell deidentified claims and eligibility data and share it with data integration firms, and page 29 lets the vendor scrub its confidential information from files sent to a successor. Ownership is present but the reuse ban the model contract requires is absent, so the majority verdict of partial stands.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"PERF","verdict":"partial","page_ref":"Page 13","evidence_quote":"With respect to the aspects of VENDOR’S performance addressed in Exhibit A, these amounts at risk are CITY’S exclusive financial remedies. The Total Dollars at risk will be $175,000 as set forth in Exhibit A.","rationale":"Two of five models read this as partial, GPT 5.6 Sol called it bad, and Gemini 3.1 Pro and Kimi K3 voted unclear because the guarantee schedule is in Exhibit A, which is not in the posted document. The body text on pages 13 and 14 is readable and settles the direction on its own, so under rule 3 the unclear votes are overruled by the substantive verdicts and the median of partial, partial and bad is partial. Page 13 says only city claims are used to measure claims operations, that penalties are settled once a year at the year end reconciliation, that the amounts at risk are the city's exclusive financial remedies, and that the total at risk is $175,000; page 14 takes any amount due off the vendor's invoice within sixty days. Guarantees exist and are plan specific, but they are annual, capped and exclusive rather than quarterly and dollar for dollar, so this is weaker than the model. Confidence is held down because the metrics themselves cannot be read.","confidence":0.55,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"ENF","verdict":"partial","page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform as defined in Exhibit A Performance Guarantees","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because there is no liquidated damages clause and no two strikes exit. Section 3.4 on page 14 does make the penalty self executing: any amount at risk comes off the vendor's invoice within sixty days without the city proving damages, and page 27 requires misappropriated funds and system overpayments to be repaid within thirty days. The trigger is the vendor's own report of its failure, the amounts are capped and exclusive under page 13, late reports carry no automatic remedy, and termination for cause on page 29 needs a single thirty day cure with no second strike or regulatory integrity exit. Automatic remedies exist in a limited form, so the majority verdict stands.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"AMD","verdict":"partial","page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"Three of five models read this as partial; GPT 5.6 Sol and Kimi K3 called it good because the amendment clause itself matches the model. Section 13.1 on page 20 and section 31.1 on page 34 do require any amendment to be written, later dated and signed by both parties. The economics can still move without a signed amendment: the MAC definition on page 2 lets the vendor amend the price list from time to time, page 8 lets the vendor add, remove or retier drugs on thirty days notice, page 9 lets it change the specialty formulary with quarterly notice, and page 1 lets it switch the pricing source after notice. The model clause bars economic changes by notice or updated list, so the majority verdict of partial stands.","confidence":0.7,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"TERM","verdict":"partial","page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause upon written notice, provided such notice specifies an effective date of termination, which shall be not less than 90 calendar days","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it good because the convenience exit is real. Section 22.2 on page 29 lets the city cancel without cause on ninety to one hundred twenty days notice, and page 19 lets it stop if funds are not appropriated, which is a genuine termination right. The same section makes the city repay a pro rata share of credits disbursed in the year of termination and of the implementation credit spread over the initial term, page 9 lets the vendor delay rebate remittance after termination, page 29 shifts record transfer costs to the city unless three years of the term are complete, and there is no regulatory integrity trigger. Those exit costs are what the model contract published by Mark Cuban and collaborators forbids, so the majority verdict stands.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"SPEC","verdict":"partial","page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease, including but not limited to, injectible, infused, or oral medication, or product that otherwise require special handling.","rationale":"Three of five models read this as partial; Gemini 3.1 Pro called it missing because no rate ceiling or acquisition cost rule appears, and Grok 4.6 called it bad because affiliated pharmacies keep purchase discounts. Section 1.13 on page 3 defines specialty by disease type and handling but leans on what the vendor uses, so the vendor draws the line. The plan runs on the vendor's Advance Control Specialty Formulary on page 9, which the vendor may change with quarterly notice, specialty is the one category exempt from the once a year removal limit on page 8, and specialty prescriptions run through the vendor's own specialty pharmacy under pages 4 and 5. No drug level ceiling and no acquisition cost pricing appears in the body, and any specialty rates would sit in the withheld Exhibit B. The subject is addressed and weaker than the model, so the majority verdict stands.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","rubric_key":"GAG","verdict":"bad","page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data, trade secrets","rationale":"All five models reached this verdict. Section 33.1 on page 34 makes costs and pricing data confidential information and has the vendor assert that parts of the contract itself are confidential. The Public Information Act clause on page 36 does not free the city: it must notify the vendor of any request, give it time to claim exemptions, not oppose the vendor's effort before the Texas Attorney General or a court, and release only the minimum ordered. Page 15 goes further and bars the rebate auditor from revealing manufacturer contract terms to any third party, including the city. The city may share data with its own consultants and auditors under page 35, but only under separate confidentiality agreements, so pricing, rebate and audit material is treated as proprietary in a way that blocks public disclosure.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.59+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"FID","verdict":"bad","page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA. Aetna has complete authority to determine whether and to what extent eligible individuals and beneficiaries are entitled to coverage and to construe any disputed or doubtful terms under this Group Agreement.","rationale":"Two of five models read this as partial, two as bad and one as missing, so no verdict had a majority; under the median rule the middle vote falls in the bad or missing tier, and a re-read of pages 10, 12 and 47 shows the text is not silent, so the verdict is bad. The only fiduciary language is section 9.4 of the Medicare Group Agreement (page 12), which makes Aetna a fiduciary solely for ERISA claim determinations and pairs that with complete authority to construe the agreement under a deferential arbitrary and capricious standard. Section 7.1 (page 10) frames the parties as independent contractors, and page 47 has the county agree that manufacturer payments belong exclusively to Aetna or CVS Caremark with no legal interest for the county. Nothing extends a duty of loyalty or care to formulary, network or pricing decisions, and the base agreement that might hold one is not in the file. Claude Opus 5 and GPT 5.6 Sol treated the narrow ERISA clause as a weaker version of the model duty; Gemini 3.1 Pro called it missing because the base agreement is absent.","confidence":0.5,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"DISC","verdict":"partial","page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because the base agreement is not in the file. The Other Payments section (pages 46 and 47) does tell the county, by category, that manufacturer administrative fees, data and education payments, network transmission fees, medical benefit specialty rebates and value based contracting payments are kept by Aetna or CVS Caremark, and page 72 notes the rates exclude commissions. That is disclosure of conflicts by category, not a full accounting of amounts, and no named officer certifies quarterly or annually that everything has been disclosed and remitted. Producer compensation information on page 85 is available only if the county asks.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"OWN","verdict":"partial","page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"Four of five models read this as partial; Gemini 3.1 Pro called it missing because there is no ownership exhibit. The file does name the corporate family in narrative form: CVS is the parent of Aetna and SilverScript (pages 31 and 72), CaremarkPCS Health and its affiliates are the pharmacy benefit manager (page 36), mail order is CVS Caremark Mail Service Pharmacy (page 31) and specialty is CVS Specialty (page 40). There is no signed exhibit listing every owner, subsidiary, group purchasing organization, rebate aggregator and affiliated pharmacy, and no duty to refresh the list within 30 days of a change in control, which is what the exhibit proposed alongside the model contract from Mark Cuban and collaborators requires.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"SPRD","verdict":"bad","page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"All five models reached this verdict. The Additional Disclosures section has the county acknowledge that the discounts and dispensing fees reflect a Traditional or Lock-In pricing arrangement (page 43) and then defines that arrangement as one where the amount charged to the county and its members may differ from the amount paid to the pharmacy, with Aetna keeping the difference on top of its other fees (page 44). That is spread pricing stated in writing. A Traditional Pricing Auxiliary Fee of $1.50 per retail claim applies in states whose laws require transparent pricing (page 52), so where the spread is forbidden a fee takes its place.","confidence":1,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"DEF","verdict":"bad","page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"Four of five models read this as bad; Gemini 3.1 Pro called it missing because the controlling definition sits in the Prescription Drug Services Schedule, which is not attached. The text that is present defines rebates by subtraction: manufacturer administrative fees, other manufacturer payments for data and education, and network transmission fees are each carved out of Rebates (page 46), and page 38 says capitalized terms in the pricing charts are not defined terms except where the missing schedule says so. Specialty is defined by the Aetna Specialty Product List (page 36), a vendor label rather than an economic function. This is the relabeling loophole the definitions article of the model contract exists to close, and the county agreed to exclusions from a definition it cannot read in this file.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"PASS","verdict":"bad","page_ref":"Page 47","evidence_quote":"Customer further agrees that the amounts described above belong exclusively to Aetna or it’s affiliate, CVS Caremark, and Customer has no right to, or legal interest in, any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"Four of five models read this as bad; Kimi K3 read it as partial because the rebate table promises the greater of 100 percent or a per brand script minimum. The rebate terms on page 37 do state minimum guarantees, but the 100 percent applies only to Rebates as narrowly defined, and pages 46 and 47 exclude administrative fees, data and education payments, network transmission fees, medical benefit specialty rebates and value based contracting payments, then have the county disclaim any legal interest in those amounts. Rebates are paid 180 days after the quarter ends (page 45) rather than within 30 days, and the guarantee excludes long lists of claims (page 41). One hundred percent of a shrunken definition, paid six months late, is not the full pass through of manufacturer revenue the model contract requires.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"NAC","verdict":"bad","page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Four of five models read this as bad; Gemini 3.1 Pro called it missing because no acquisition cost clause exists in the file. Mail order is filled by CVS Caremark Mail Service Pharmacy (page 31) and specialty must be filled at CVS Specialty pharmacies with no retail fills (page 40), so the affiliated channels carry most of the spend. Those channels are priced as discounts off average wholesale price, for example mail brand at AWP minus 19.50 percent and specialty at AWP minus 22.75 percent in 2026 (page 36), under a traditional pricing arrangement that lets Aetna keep the difference between what the county pays and what the pharmacy receives (page 44). Nothing prices an affiliate claim at net acquisition cost plus a stated dispensing fee, and there is no documentation default if cost records are not produced.","confidence":0.85,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"CEIL","verdict":"partial","page_ref":"Page 57","evidence_quote":"If the price is lower through a non-Aetna contracted network (including an administrative fee paid to the third-party that contracts the network), the Claim will be processed through that network.","rationale":"Three of five models read this as partial; Grok 4.6 and Kimi K3 called it missing because the lesser of language on page 39 protects only the member at the counter, not what the plan is charged. The Caremark Cost Saver footnote on page 57 does compare the Aetna network price with a non Aetna network price claim by claim and routes the claim to the cheaper one, and page 39 gives the member the lesser of usual and customary, MAC or discounted AWP. Neither is a ceiling tied to a published benchmark such as a transparent cash price, neither covers every drug and channel, and Aetna reserves the right to re-evaluate pricing when its assumptions change (page 40). The protection is real but narrow, which is why partial stands with modest confidence.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"CASH","verdict":"partial","page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy’s Usual and Customary Charge, (iii) MAC (where applicable) or (iv) discounted AWP cost.","rationale":"Four of five models read this as partial; Kimi K3 called it missing because the lesser of clause is a pharmacy pricing term rather than a member right. At a participating pharmacy the member pays the lesser of the cost share, the pharmacy usual and customary charge, MAC or the discounted AWP price (page 39), which stops the member from paying more through the plan than the pharmacy cash price at that counter. Nothing lets a member fill outside the plan at a lower cash price and have it count toward the deductible or out of pocket maximum, and the PrudentRx guarantee on page 43 assumes a true accumulation plan design without any written election by the county. The model clause from Mark Cuban and collaborators covers both halves; this text covers one.","confidence":0.8,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"MAC","verdict":"bad","page_ref":"Page 40","evidence_quote":"MAC: Certain dosage forms and strengths may not be included on the MAC list and shall be priced at the Specialty Product default rate.","rationale":"Two of five models read this as partial, two as missing and one as bad, so no verdict had a majority; the median falls in the bad or missing tier, and the rule for that tie is to re-read the pages the bad voter cited and ask whether the text permits the harm or is merely silent. It permits it. MAC pricing applies at mail order (page 39) and dozens of specialty generics on pages 59 to 71 are priced at MAC, yet the county is on a traditional or lock in arrangement under which the amount charged to the county for a network claim may differ from the amount paid to the pharmacy and Aetna keeps the difference (pages 43 and 44). That is a contractual license for one price list on the county side and another on the pharmacy side, which is the two list harm the model MAC clause exists to prevent. No MAC list is disclosed, no update schedule is set and no pharmacy appeal path with timelines appears; Claude Opus 5 and GPT 5.6 Sol treated the passing references as a weak form of governance, and Gemini 3.1 Pro and Kimi K3 read the same passages as silence. Confidence is low because only Grok 4.6 reached this verdict directly.","confidence":0.4,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"GPO","verdict":"bad","page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates.","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Kimi K3 called it missing because no group purchasing organization or rebate aggregator is named anywhere in the file. The text never uses those words, but it does describe the money such entities collect: payments from drug manufacturers and other organizations for data and education (page 46), network transmission fees from pharmacies (page 46), and on page 47 the county agrees these amounts are earned across the Aetna book of business and belong exclusively to Aetna or its affiliate CVS Caremark. Nothing requires purchase discounts, volume credits or supplier payments received by any related purchasing entity to flow to the plan. The majority read that as affirmatively permitting the leakage rather than staying silent about it.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"FORM","verdict":"partial","page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"All five models reached this verdict. The Formulary Management section (page 46) gives the county sole discretion to accept or reject the formulary, but only from options Aetna decides to offer, and Aetna may propose changes based on market conditions, clinical information, cost, rebates and other factors. Pricing and rebate guarantees are conditioned on the Aetna Standard Formulary, the Choose Generics program and the Advanced Control Specialty Formulary (pages 40 and 41), and a custom formulary with net cost analysis is a priced extra at $100,000 (page 53). There is no requirement that the county approve every change, receive lowest net cost analysis or get utilization management outcomes by drug each quarter.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"LNC","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"All five models reached this verdict. The formulary section on page 46, the rebate terms on pages 41 and 42, the market check on page 43 and the additional services list on pages 53 to 57 were all searched. Page 46 names cost and rebates among the reasons Aetna may propose formulary changes but sets no lowest net cost standard for this plan, and net cost analysis appears only as a feature of the $100,000 custom formulary service on page 53. No annual comparison against the Aetna book of business is promised, and the base agreement that might hold such a standard is not in the file.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"NET","verdict":"bad","page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Four of five models read this as bad; Gemini 3.1 Pro called it missing because the base agreement is not in the file. Page 40 requires members to use CVS Specialty pharmacies with no retail fills, conditions the specialty discount on Aetna being the exclusive specialty provider except for the HIV class, and lets Aetna amend pricing if retail leakage rises 10 percent or more. Mail order is likewise routed to CVS Caremark Mail Service Pharmacy (page 31) and the P1 preferred network charges members more at standard pharmacies (page 31). That is steering into pharmacies owned by the vendor's parent, with no any willing pharmacy right, no bar on retroactive clawbacks and no protection for independent pharmacies.","confidence":0.9,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"MFN","verdict":"partial","page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"All five models reached this verdict. The Market Check section (page 43) allows an annual review in the second quarter of each contract year, by Aetna and the county or a mutually agreed third party under a non-disclosure agreement, against offers made to similar employers. If the review shows savings of 2 percent or more in net costs the only remedy is a good faith discussion, and any agreed change takes effect the following January 1. There is no automatic most favored pricing promise and no meet, credit or release right, so the clause is real but weaker than the model.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"AUD","verdict":"partial","page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"All five models reached this verdict. Pharmacy Audit Rights and Limitations (page 48) grants one rebate audit and one electronic claim audit a year, at the county's own expense unless otherwise agreed, and both are subject to audit terms in the Prescription Drug Services Schedule, which is not in the file. Audit claim files for data over 24 months old cost $5,000 per file and historical claims data costs $1,000 per file (page 54). There is no right to full claims level and financial data on a schedule without asking, no pre-adjudication access and no statement that nothing will be withheld as proprietary.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"DATA","verdict":"bad","page_ref":"Page 54","evidence_quote":"Refill Transfers upon termination $4,500 Per file Precertification history $3,500 Per file Accumulator files $1,000 Per file Historical claims data $1,000 Per file","rationale":"Three of five models read this as bad; Gemini 3.1 Pro and Grok 4.6 called it missing because no clause states who owns the data either way. The majority pointed to the Vendor Transition Files table (page 54), which charges the county per file for its own accumulator files, historical claims data, precertification history and refill transfers at termination, and to page 46, where Aetna is paid by manufacturers for the analysis or provision of aggregated data. Nothing in the file says the county owns its claims, eligibility, accumulator or rebate data, that it is delivered in machine readable form on request, or that Aetna may not reuse or sell it. Pricing a public body's access to its own records is the switching barrier the model clause exists to prevent, which is why the majority read the text as permitting the harm rather than staying silent.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"PERF","verdict":"partial","page_ref":"Page 42","evidence_quote":"Rebate guarantees are measured individually by component and reconciled in the aggregate on an annual basis within 12 months following the end of the Plan year; a surplus in one or more component Rebate guarantees may be used to offset shortages in other component Rebate guarantees.","rationale":"Three of five models read this as partial; GPT 5.6 Sol read it as bad because the PrudentRx remedy is a capped credit, and Gemini 3.1 Pro called it missing because the base agreement is absent. Discount, dispensing fee and rebate guarantees do exist and are reconciled, and page 39 keeps discount and dispensing fee components from offsetting each other. The rebate side is weaker: components are reconciled in the aggregate up to 12 months after the plan year (page 42), discount reconciliation can take 180 days (page 39), and the PrudentRx savings guarantee pays out as a credit against future billing capped at 30 percent of the program cost (page 43). Guarantees measured annually with offsets and capped credits are weaker than the quarterly, dollar for dollar cash remedies in the model.","confidence":0.65,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"ENF","verdict":"missing","page_ref":null,"evidence_quote":null,"rationale":"Three of five models read this as missing; Claude Opus 5 and GPT 5.6 Sol read it as partial because the PrudentRx credit on page 43 pays without the county proving damages. The guarantee reconciliations on pages 39 to 43 are performance true ups on specific programs, not a general rule that missed guarantees or late reports trigger liquidated damages or automatic credits. The termination article of the Medicare Group Agreement on pages 8 and 9 has no two strikes or repeat breach exit, and the only self executing remedies in the file run against the county: 12.0 percent annual late payment interest (page 48) and the Early Termination Fee (page 47). A general enforcement clause would live in the base agreement, which is not in the file.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"AMD","verdict":"bad","page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"All five models reached this verdict. Section 9.17 of the Medicare Group Agreement (page 14) lists three ways to amend: automatically to conform with regulatory mandates, by mutual written agreement, or by Aetna alone on 30 days written notice, and adds that all amendments must be approved and executed by Aetna. The pharmacy schedule adds further one sided rights: Aetna may amend individual specialty drug discounts to manage its guarantee (page 40) and may make an Equitable Adjustment to the financial provisions on stated triggers, some effective 30 days after notice (page 44). The model contract allows changes only when both parties sign.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"TERM","verdict":"bad","page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna’s arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an “Early Termination”) Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein.","rationale":"All five models reached this verdict. Section 5.1 of the Medicare Group Agreement lets either party terminate without cause on 90 days notice (page 8), but the pharmacy schedule takes the value back: if the county ends pharmacy services before December 31, 2028, Aetna keeps earned but unpaid rebates, the year's pharmacy guarantees become null and void and are not reconciled, and the county must refund prorated allowances, all labeled liquidated damages and an Early Termination Fee due within 60 days (page 47). Forfeiting earned money on exit is the trap the model termination clause exists to remove.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"SPEC","verdict":"bad","page_ref":"Page 40","evidence_quote":"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee.","rationale":"Three of five models read this as bad; Claude Opus 5 and Gemini 3.1 Pro read it as partial because the drug level discount table on pages 59 to 71 is unusually detailed. Specialty is defined by the Aetna Specialty Product List (page 36), a vendor label rather than an economic function, and members must use CVS Specialty pharmacies with Aetna as exclusive provider except for HIV drugs (page 40). Pricing is a blended AWP minus 22.75 percent guarantee in 2026 (page 36) with drug level rates that Aetna may amend to manage its own guarantee, new to market products at AWP minus 16.00 percent and a default rate of 17.00 percent (pages 40 and 71). Drug level rates that the vendor can move are not a ceiling, and nothing prices affiliate specialty claims at acquisition cost, so the majority read the text as contradicting the model rather than weakening it.","confidence":0.6,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","rubric_key":"GAG","verdict":"bad","page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna’s prior written consent.","rationale":"All five models reached this verdict. The Financial Conditions document (page 27) bars Harris County from releasing the pricing proposal to any third party without Aetna's written consent, and section 9.20 of the Medicare Group Agreement (page 14) sweeps the agreement itself and costs and pricing data into Confidential Information that may not be disclosed without consent. The Public Records Acts clause (page 22) acknowledges the county is subject to disclosure law but requires notice to Aetna, time to claim exemptions, a promise not to oppose Aetna's court action to block release, and disclosure of only the minimum a court orders. Every pricing exhibit carries a not for further distribution legend. That combination treats what taxpayers pay as the vendor's secret, so the red flag is set.","confidence":0.95,"reviewed_by":"owner","reviewed_at":"2026-09-05T21:14:52.934+00:00"}],"license":"Public record. Attribution appreciated: BetterBuy Rx PBM Commons, betterbuyrx.com/commons"}